COMPANY PROFILE / #626
Iambic
San Diego, CAVenture Capital-Backed
OVERVIEW
Developer of an AI-driven drug discovery platform designed to support the development of precision therapeutics. The company leverages multimodal transformer models, co-folding AI technologies, and high-throughput experimentation to optimize drug candidates and discover novel treatments for cancer and other diseases, enabling pharmaceutical partners to improve drug development efficiency and therapeutic outcomes.
已融资354.77
最新估值648.00
员工数153
成立年份2019
公司概况
- Companies
- Iambic
- Description
- Developer of an AI-driven drug discovery platform designed to support the development of precision therapeutics. The company leverages multimodal transformer models, co-folding AI technologies, and high-throughput experimentation to optimize drug candidates and discover novel treatments for cancer and other diseases, enabling pharmaceutical partners to improve drug development efficiency and therapeutic outcomes.
- Website
- iambic.ai
- HQ Location
- San Diego, CA
- Year Founded
- 2019
- Keywords
- biotechnology research tool, discovery platform, molecular research, molecule therapeutics, therapeutic discovery, therapeutic discovery platform
- Competitors
- Relay Therapeutics, insitro, Scorpion Therapeutics, Exscientia, BPS Bioscience, Revolution Medicines, AbCellera Biologics, Eikon Therapeutics, Terray Therapeutics, Generate Biomedicines, Recursion Pharmaceuticals, Berg, Schrodinger
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 354.77
- First Financing Date
- —
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 08-Apr-2026
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- —
- Last Financing Valuation
- 648.00
- Last Financing Status
- —
- Last Known Valuation
- 648.00
- Last Known Valuation Date
- 08-Apr-2026
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- —
- Valuation Estimate Growth Rate
- 28.59%
- Active Investors
- Abingworth, Alexandria Venture Investments, Alumni Ventures, ARK Ventures (US), Ascenta Capital, Bill Rastetter, Catalio Capital Management, Chestnut Street Ventures, Coatue Management, Deviation Capital, Eisai Innovation, EverBright, Everbright Biofund, Exor, Freeflow Ventures, Gradiant, Illumina Ventures, Mubadala Capital, Nexus Venture Partners, Nvidia, OrbiMed, Pegasus Tech Ventures, Qatar Investment Authority, Regeneron Ventures, Schmidt Sciences, Sequoia Capital, Shanda (Private Equity), Tao Capital, Tao Capital Partners, Terra Magnum Capital Partners, University of Bristol, Wilson Sonsini Goodrich & Rosati Professional
- # Active Investors
- —
- Acquirers
- —
团队与联系人
- Employees
- 153
- Employee Growth %
- —
- Employee History
- 2026: 153, 2025: 119, 2024: 80, 2023: 59, 2022: 44, 2021: 25
- Primary Contact
- Thomas Miller
- Primary Contact Title
- Co-Founder, Chief Executive Officer & Board Member
- Primary Contact Email
- tom@iambic.ai
- Primary Contact Phone
- +1 (619) 330-5499
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- -1.98%
- Growth Rate % Change
- -5.08%
- Growth Rate Percentile
- 2
- Size Multiple
- 18.91x
- Size Multiple % Change
- 7.97%
- Size Multiple Change
- 1.40x
- Size Multiple Percentile
- —
- Majestic Referring Domains
- 341
- SimilarWeb Unique Visitors
- 2,360
- SimilarWeb Unique Visitors Change
- -446
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- 3
- Success Probability Over Time – 1 Year
- 44%
- Success Probability Over Time – 3 Year
- 68%
- Success Probability Over Time – 5 Year
- 80%
记录来源：public.companies · 原始序号 #626 · 所有字段均按数据库原值展示。